Organigram Global (OGI) Gains from Investment Securities (2018 - 2026)

Organigram Global (OGI) posted quarterly Gains from Investment Securities of -$4.8 million for Q1 2026, down 272.08% on a QoQ basis from -$1.3 million in Q4 2025.

Organigram Global (OGI) Gains from Investment Securities (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Gains from Investment Securities for 6 consecutive years, with -$4.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.8 million (changed N/A YoY) and the FY2025 annual result came in at $6539.7, up 101.41% from the prior year.
  • Gains from Investment Securities eased to -$4.8 million in Q1 2026 per OGI's latest filing, from -$1.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for OGI reached as high as -$1.3 million in Q4 2025 and fell as low as -$4.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Organigram Global 121.15 Mn 154.23 Mn 28.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.83 Mn
Mar 31, 2026 -4.83 Mn
Dec 31, 2025 -1.30 Mn
Dec 31, 2025 -1.30 Mn
May 31, 2021 166,000.00
May 31, 2021 166,000.00
Feb 28, 2021 190,000.00
Feb 28, 2021 190,000.00
Nov 30, 2020 4.67 Mn
Nov 30, 2020 4.67 Mn
May 31, 2020 -164,472.40
May 31, 2020 -164,472.40
Feb 29, 2020 -193,000.00
Feb 29, 2020 -193,000.00
Nov 25, 2019 145,000.00
Nov 25, 2019 145,000.00
May 31, 2019 271,042.41
May 31, 2019 271,042.41
Feb 28, 2019 663,000.00
Feb 28, 2019 663,000.00